Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 64,788 | 75,975 | N/A | N/A |
| Marketable Securities | 71,612 | N/A | N/A | N/A |
| TOTAL | $138,049 | $77,131 | $N/A | $N/A |
| Non-Current Assets | ||||
| Other Non-Current Assets | 69 | 20 | 0 | 0 |
| TOTAL | $69 | $20 | $N/A | $N/A |
| Total Assets | $138,118 | $77,151 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 947 | 1,373 | 0 | 0 |
| Accrued Expenses | 8,422 | 969 | N/A | N/A |
| TOTAL | $9,369 | $2,342 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 23 | 124,728 | 0 | 0 |
| TOTAL | $23 | $124,728 | $N/A | $N/A |
| Total Liabilities | $9,392 | $127,070 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 28,608 | N/A | N/A | N/A |
| Common Shares | 3 | N/A | N/A | N/A |
| Retained earnings | -130,320 | -86,565 | N/A | N/A |
| Other shareholders' equity | -6 | 0 | 0 | 0 |
| TOTAL | $128,726 | $-49,919 | $N/A | $N/A |
| Total Liabilities And Equity | $138,118 | $77,151 | $0 | $0 |